Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel

Season 2 Episode 92  ·  Aug 28, 10:00 AM
Headliner
Share
Subscribe
Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relapsed/refractory multiple myeloma.
Share
Subscribe
Next
Food, Fungals, and Flexibility: Real-World Dosing of Revumenib
Top episodes
Pharmacy Focus: Independent Rx Forum - DIR Changes
by Pharmacy Focus
Independent Rx Forum - Preparing for DIR Fee Changes
by Pharmacy Focus
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
by Pharmacy Focus